Literature DB >> 17154170

Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study.

Elisa Martró1, Anna Esteve, Thomas F Schulz, Julie Sheldon, Gemma Gambús, Rafael Muñoz, Denise Whitby, Jordi Casabona.   

Abstract

We aimed to identify risk factors for Kaposi's sarcoma (KS) among HIV-positive patients and behaviors associated with human Herpesvirus 8 (HHV-8) infection, as well as to assess KS incidence and mortality rates longitudinally. To fulfill the first objective, a European case-control study was designed in the early 1990s (each KS case was matched to 2 controls with another AIDS indicative disease). After the discovery of HHV-8, serology testing enabled us to assess risk factors for KS development among HHV-8 and HIV-1 coinfected men who have sex with men (MSM), as well as risk factors for HHV-8 infection. HHV-8 seroprevalence was determined using a latent immunofluorescence assay. Relevant information was obtained by means of a questionnaire and medical charts review. Assessment of risk factors for KS development and HHV-8 infection was performed using conditional and unconditional logistic regression models, respectively. A low CD4 count was the only significant risk factor for KS. HHV-8 infection was most strongly linked to the number of life-time sex partners, and multiple body fluids such as saliva and semen are quite likely involved in sexual transmission. Longitudinal follow up showed a significant protective role for highly-active antiretroviral therapy (HAART) both on KS development and mortality of KS patients. Although more conclusive data from cohort studies are needed to better define specific transmission mechanisms for HHV-8, our results contribute to explain why KS incidence is higher among MSM, and the decreasing KS incidence trend observed in countries with universal access to HAART. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2007        PMID: 17154170     DOI: 10.1002/ijc.22281

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Kaposi's sarcoma and its associated herpesvirus.

Authors:  Enrique A Mesri; Ethel Cesarman; Chris Boshoff
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

Review 2.  Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Denise Whitby
Journal:  Cancer Lett       Date:  2011-03-04       Impact factor: 8.679

Review 3.  Serodiagnosis for tumor viruses.

Authors:  Brian J Morrison; Nazzarena Labo; Wendell J Miley; Denise Whitby
Journal:  Semin Oncol       Date:  2014-12-31       Impact factor: 4.929

4.  Longitudinal Viral Dynamics in Semen During Early HIV Infection.

Authors:  Sheldon R Morris; Mitchell Zhao; Davey M Smith; Milenka V Vargas; Susan J Little; Sara Gianella
Journal:  Clin Infect Dis       Date:  2017-02-15       Impact factor: 9.079

5.  Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study.

Authors:  Vickie Marshall; Elisa Martró; Nazzarena Labo; Alex Ray; Dian Wang; Georginia Mbisa; Rachel K Bagni; Natalia Volfovsky; Jordi Casabona; Denise Whitby
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

6.  Prevalence and correlates of human herpesvirus 8 infection among Peruvian men who have sex with men.

Authors:  Juan V Guanira; Corey Casper; Javier R Lama; Rhoda Morrow; Silvia M Montano; Patricia Caballero; Luis Suárez; William L H Whittington; Anna Wald; Jorge Sanchez; Connie Celum
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-15       Impact factor: 3.731

7.  Update on HHV-8-Associated Malignancies.

Authors:  Meena Sunil; Erin Reid; Mary Jo Lechowicz
Journal:  Curr Infect Dis Rep       Date:  2010-03-26       Impact factor: 3.725

8.  Human herpesvirus 8 seroprevalence among Tobago women and the role of sexual lifestyle behavior.

Authors:  Alicia C McDonald; Camille C Ragin; Frank J Jenkins; Joel Weissfeld; John Wilson; Victor W Wheeler; Jaquie B Wilson; Clareann H Bunker; Emanuela Taioli
Journal:  J Med Virol       Date:  2009-02       Impact factor: 2.327

Review 9.  Oral complications of HIV disease.

Authors:  Jair C Leao; Camila M B Ribeiro; Alessandra A T Carvalho; Cristina Frezzini; Stephen Porter
Journal:  Clinics (Sao Paulo)       Date:  2009-05       Impact factor: 2.365

10.  Variation in Cancer Incidence among Patients with ESRD during Kidney Function and Nonfunction Intervals.

Authors:  Elizabeth L Yanik; Christina A Clarke; Jon J Snyder; Ruth M Pfeiffer; Eric A Engels
Journal:  J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 14.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.